论文部分内容阅读
目的:探讨凯西莱联合胸腺肽治疗慢性乙型肝炎临床疗效。方法:随机将住院患者分为治疗组和对照组各50例。治疗组:在综合治疗的基础上,加用凯西莱联合胸腺肽,其中凯西莱0.2g加入10%葡萄糖250ml,静脉点滴,胸腺肽100mg加入10%葡萄糖250ml,静脉点滴;对照组:口服复方益肝灵片,静脉点滴维生素C、能量合剂等,疗程3个月。结果:治疗组与对照组相比,临床症状、体征、肝功能的改善或复常时间差异均有统计学意义(P<0.01)。结论:凯西莱联合胸腺肽治疗慢性乙型肝炎,既能促进肝细胞的恢复,改善肝功能,又能抑制HBV的复制,且起效快,肝功能不易反跳,值得临床推广应用。
Objective: To investigate the clinical efficacy of combination of thiazide and thymosin in the treatment of chronic hepatitis B. Methods: Inpatients were randomly divided into treatment group and control group of 50 cases. Treatment group: On the basis of comprehensive treatment, combined with Cassie combined thymosin, which Cassielet 0.2g added 10% glucose 250ml, intravenous drip, thymosin 100mg 10% glucose 250ml, intravenous drip; control group: oral Fufang Yi Liver tablets, intravenous vitamin C, energy mixture, treatment for 3 months. Results: Compared with the control group, the clinical symptoms, signs, the improvement of liver function or the time of recovery were all statistically significant (P <0.01). Conclusion: The combination of thoracic acid and thymosin in the treatment of chronic hepatitis B can promote the recovery of hepatocytes, improve the liver function, inhibit the replication of HBV, and have rapid onset and rapid rebound of liver function, which is worthy of clinical application.